AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
TEL AVIV, ISRAEL, November 8, 2024 /EINPresswire.com/ -- Currently, home ECG readings either use a simple device to record a 1-Lead ECG trace (which just measures the signal from left-hand to right hand), or require the user to attach electrodes to the leg and/or chest in order to provide a more detailed picture. Attaching such additional electrodes requires partial undressing and is cumbersome and complex. OmnySense has invented a way of providing a full 3/6-Lead ECG without requiring the placement of additional electrodes on the body. The technology to accomplish this involves exploiting the metallic tip of a “smart-thermometer” device as an ECG electrode, and implementing a transformation of the signals detected between the fingers (on the device) and the mouth into a standard 3/6-Lead trace. This method allows for the detection of anomalies across six pathways of the heart, significantly enhancing the ability to detect cardiac problems compared to the limited 1-Lead ECG. This ability, together with OmnySense algorithms for calculating the standard cardiac parameters from the signal detected across each lead, provides a powerful tool for tracking cardiac performance and enabling analysis using the company’s AI approach.
OmnySense Ltd., an Israeli digital-health startup, is developing a unique solution which provides the home user with an informed medical assessment at home, powered by state-of-the-art Medical Language Models (Med LMs). The company’s thermometer-shaped device is the only one capable of capturing a comprehensive dataset of clinical parameters simultaneously and consistently, including cardiac data from 6 leads, respiratory data and vital signs. This dataset - together with the patient’s symptoms and medical history - is analyzed using Med LMs to provide an automatic assessment directly to the user, and can also be shared with a remote physician, caregiver etc.
Ian Solomon, CTO of OmnySense, stated: "We are delighted to have been awarded this US patent, which we see as validating the originality of our next-generation smart-thermometer technology. This breakthrough technology places high-end ECG analysis directly into the hands of the consumer, with the ability to provide him/her with automatic medical assessments based on a very broad dataset. The applications are numerous, from monitoring cardiac conditions at home to supporting cardiac rehabilitation.”
Ian Solomon
OmnySense Ltd
+972 50-779-1493
[email protected]
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
